ULTRAGESIC 150mg CAPSULA DE LIBERACION PROLONGADA
국가: 페루
언어: 스페인어
출처: DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)
제품 특성 요약
(SPC)
22-01-2018
이 제품에 대한 일부 문서는 현재 사용할 수 없습니다. 고객 서비스에 요청을 보내면 가능한 빨리 알려 드리겠습니다.
요청을 보내십시오.
요청을 보내십시오.
제공처:
TECNOFARMA S.A.
ATC 코드:
N02AX02
약제 형태:
CAPSULA DE LIBERACION PROLONGADA
구성:
POR CAPSULA; CLORHIDRATO DE TRAMADOL 150.000000 mg;
관리 경로:
ORAL
패키지 단위:
Caja de cartulina conteniendo 2, 5 y 10 cápsulas de liberación prolongada en blíster de PVC/Aluminio/OPA - Aluminio plateado
처방전 유형:
CON RECETA MEDICA RETENIDA
Manufactured by:
GALEPHAR PHARMACEUTICAL RESEARCH INC
치료 그룹:
Tramadol
제품 요약:
Presentacion: Caja de cartulina conteniendo 2, 5 y 10 cápsulas de liberación prolongada en blíster de PVC/Aluminio/OPA - Aluminio plateado
승인 상태:
CANCELADO
승인 날짜:
2023-01-18
제품 특성 요약
H>DZ' ^/ϬΡϬŴŐĐĄƉƐƵŮĂĚĞŮŜĎĞƋĂĐŜSŶƉƋŽŮŽŶŐĂĚĂ
Π
DƋĂŴĂĚŽŮĐŮŽƋŚŜĚƋĂȽŽ
)Ï508/$
&DGDFiSVXODGHOLEHUDFLyQSURORQJDGDGHPJFRQWLHQH
7UDPDGROFORUKLGUDWR««««««««PJ
([FLSLHQWHV
&HOXORVD0LFURFULVWDOLQD $YLFHOS+\$YLFHOS+ (VWHDUDWRGH6DFDURVD+LGUR[LSURSLOPHWLOFHOXORVD 7DOFR(VWHDUDWR
GH0DJQHVLR3ROLVRUEDWR(PXOVLyQGH6LPHWLFRQD(XGUDJLW1('/DFWRVD0RQRKLGUDWR3RYLGRQD.$OPLGyQGHPDt]
$OPLGyQ*OLFRODWR6yGLFR
,1)250$&,21&203/(7$3$5$/$35(6&5,3&,21
$'9(57(1&,$ $',&&,21$%862<862,1'(%,'2 '(35(6,215(63,5$725,$&215,(6*2'(9,'$
0(7$%2/,6028/75$5È3,'2'(/75$0$'2/<27526)$&725(6'(5,(6*23$5$/$'(35(6,Ï1
5(63,5$725,$&215,(6*2'(9,'$(1/261,F26 ,1*(67,21$&&,'(17$/ 6,1'520('(
$%67,1(1&,$23,2,'(1(21$7$/ ,17(5$&&,21(6&21'52*$648($)(&7$1/$6,62(1=,0$6'(/
&,72&52023<5,(6*26325862&21&20,7$17(&21%(1=2',$=(3,1$6827526
'(35(625(6'(/61&
$GLFFLYQ DEXVR \ XVR LQGHELGR 8/75$*(6,& H[SRQH D ORV
SDFLHQWHV \ D RWURV XVXDULRV D ULHVJRV GH
DGLFFLYQDEXVR \XVRLQGHELGRGHRSLRLGHVTXHSXHGHQ FRQGXFLUD
OD VREUHGRVLV \ DODPXHUWD (YDO~H HO
ULHVJRGHFDGDSDFLHQWHDQWHVGHSUHVFULELU8/75$*(6,&\FRQWUROHDWRGRVORVSDFLHQWHVHQIRUPDUHJXODU
SDUDGHWHFWDUODDSDULFLYQGHHVWDVFRQGXFWDV\WUDVWRUQRV[ver
Advertencias y Precauciones (5.1)]'HSUHVLYQ
UHVSLUDWRULDFRQULHVJRGHYLGD
&RQ HO XVR GH 8/75$*(6,& SXHGH SURGXFLUVH GHSUHVLYQ
UHVSLUDWRULD JUDYH FRQ ULHVJR GH YLGD R IDWDO
&RQWUROHSDUDGHWHFWDUODGHSUHVLYQUHVSLUDWRULDHQHVSHFLDOGXUDQWHHOLQLFLRGH8/75$*(6,&RGHVSXPVGH
XQDXPHQWRGHGRVLV,QVWUX\DDORVSDFLHQWHVTXHWUDJXHQODVFISVXODVGH8/75$*(6,&LQWDFWDVVLQSDUWLU
URPSHU PDVWLFDU DSODVWDU R GLVROYHU ORV FRQWHQLGRV GH ODV
FISVXODV SDUD HYLWDU H[SRVLFLYQ D XQD GRVLV
SRWHQFLDOPHQWHIDWDOGHWUDPDGRO[Ver Advertencias y precauciones
(5.2)].
전체 문서 읽기
